Silodosin Recordati Unia Europejska - polski - EMA (European Medicines Agency)

silodosin recordati

recordati ireland ltd - silodosyna - hiperplazja prostaty - urologicals, alfa-adrenergicznych antagoniści - leczenie oznaki i objawy korzystny sterczowy hyperplasia (bph) u mężczyzn w wieku.

Enteroporc Coli AC Unia Europejska - polski - EMA (European Medicines Agency)

enteroporc coli ac

ceva santé animale - clostridium perfringens type c, beta1 toxoid / clostridium perfringens, type a, alpha toxoid / clostridium perfringens, type a, beta2 toxoid / escherichia coli, fimbrial adhesin f4ab / escherichia coli, fimbrial adhesin f4ac / escherichia coli, fimbrial adhesin f5 / escherichia coli, fimbrial adhesin f6 - immunologicals for suidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) escherichia + clostridium - wieprzowy - for the passive immunisation of progeny by active immunisation of pregnant sows and gilts to reduce:-           clinical signs (severe diarrhoea) and mortality caused by escherichia coli strains expressing the fimbrial adhesins f4ab, f4ac, f5 and f6-           clinical signs (diarrhoea during the first days of life) associated with clostridium perfringens type a expressing alpha and beta 2 toxins-           clinical signs and mortality associated with haemorrhagic and necrotising enteritis caused by clostridium perfringens type c expressing beta1 toxin.

Nexviadyme Unia Europejska - polski - EMA (European Medicines Agency)

nexviadyme

sanofi b.v. - avalglucosidase alfa - choroba związana z przechowywaniem glikogenu typu ii - inne przewodu pokarmowego i przemianę materii narzędzia, - nexviadyme (avalglucosidase alfa) is indicated for long-term enzyme replacement therapy for the treatment of patients with pompe disease (acid α-glucosidase deficiency).

Elfabrio Unia Europejska - polski - EMA (European Medicines Agency)

elfabrio

chiesi farmaceutici s.p.a - pegunigalsidase alfa - fabry disease - inne przewodu pokarmowego i przemianę materii narzędzia, - elfabrio is indicated for long-term enzyme replacement therapy in adult patients with a confirmed diagnosis of fabry disease (deficiency of alpha-galactosidase).